Mesoblast Limited (MESO) has a consensus analyst rating of Buy, based on 11 analysts covering the stock. Of those, 5 recommend buying, 4 recommend holding, and 2 recommend selling.
The analyst consensus price target for MESO is $11.50, representing a -21.3% downside from the current price of $14.61. Price targets range from a low of $11.00 to a high of $12.00.
